Publications

Journal Articles

  1. & Dapagliflozin and renal function. Re: Diabetes and kidney disease: the role of sodium–glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes. Mende CW. Curr Med Res Opin 2017;33:541-551. Current Medical Research and Opinion, 1-2.
  2. & Obesity-related hypogonadism: a reversible condition. BMJ Case Reports, bcr-2017-220416
  3. & Temporal Effect of Bariatric Surgery on Predicted 10-Year and Lifetime Cardiovascular Risk at 1 Month, 6 Months, and 5 Years Following Surgery: A Pilot Study. Metabolic Syndrome and Related Disorders 15(3), 130-136.
  4. & A pilot service-evaluation examining change in HbA1c related to the prescription of internet-based education films for type 2 diabetes. Primary Care Diabetes 11(3), 305-308.
  5. & Bariatric Surgery Is Accompanied by Changes in Extracellular Vesicle-Associated and Plasma Fatty Acid Binding Protein 4. Obesity Surgery
  6. & A non-exercise method to determine cardiorespiratory fitness identifies females predicted to be at 'high risk of type 2 diabetes. Diabetes and Vascular Disease Research 14(1), 47-54.
  7. & Ghrelin function in human obesity and type 2 diabetes: a concise review. Obesity Reviews 18(2), 140-148.
  8. & Metabolic Effects Associated with ICS in Patients with COPD and Comorbid Type 2 Diabetes: A Historical Matched Cohort Study. PLOS ONE 11(9), e0162903
  9. & Telomere length, antioxidant status and incidence of ischaemic heart disease in type 2 diabetes. International Journal of Cardiology 216, 159-164.
  10. & The clinical management of hyponatraemia. Postgraduate Medical Journal, postgradmedj-2015-133740
  11. & Temporal changes in plasma markers of oxidative stress following laparoscopic sleeve gastrectomy in subjects with impaired glucose regulation. Surgery for Obesity and Related Diseases
  12. & Molecular Characterisation of Small Molecule Agonists Effect on the Human Glucagon Like Peptide-1 Receptor Internalisation. PLOS ONE 11(4), e0154229
  13. & Pharmacokinetic, pharmacodynamic and clinical evaluation of saxagliptin in type 2 diabetes. Expert Opinion on Drug Metabolism & Toxicology 12(4), 467-473.
  14. Examining the relationship between HbA1c and diabetes risk models in a European population indicates a lower threshold to identify 'high risk is required. Diabetes and Vascular Disease Research
  15. & Changes in Cognitive Function Following Bariatric Surgery: a Systematic Review. Obesity Surgery 26(10), 2530-2537.
  16. & Predicting the Resolution of Type 2 Diabetes after Bariatric Surgical Procedures: A Concise Review. Journal of Diabetes & Metabolism 6(10)
  17. Targeting abdominal obesity in diabetes. Diabetes Management 5(4), 301-309.
  18. & Follicular variant of papillary thyroid carcinoma: an unusual cause of thyrotoxicosis. Case Reports 2015(may06 1), bcr2014207091-bcr2014207091.
  19. & Association between the preoperative fasting and postprandial C-peptide AUC with resolution of type 2 diabetes 6months following bariatric surgery. Metabolism
  20. & Combination therapy with saxagliptin and dapagliflozin for the treatment of type 2 diabetes. Expert Opinion on Pharmacotherapy 16(15), 2373-2379.
  21. & Renal function and dapagliflozin in routine clinical practice. Journal of Diabetes 7(4), 591-592.
  22. & Bariatric surgery as a treatment for idiopathic intracranial hypertension: a systematic review. Surgery for Obesity and Related Diseases
  23. & Cardiorespiratory fitness is a stronger indicator of cardiometabolic risk factors and risk prediction than self-reported physical activity levels. Diabetes and Vascular Disease Research 12(6), 428-435.
  24. & Different type 2 diabetes risk assessments predict dissimilar numbers at 'high risk': a retrospective analysis of diabetes risk-assessment tools. British Journal of General Practice 65(641), e852-e860.
  25. & Changes in Plasma Levels of N-Arachidonoyl Ethanolamine and N-Palmitoylethanolamine following Bariatric Surgery in Morbidly Obese Females with Impaired Glucose Homeostasis. Journal of Diabetes Research 2015, 1-8.
  26. & Changes in inflammatory markers after sleeve gastrectomy in patients with impaired glucose homeostasis and type 2 diabetes. Surgery for Obesity and Related Diseases 10(6), 1123-1128.
  27. & Changes in markers of oxidative stress and DNA damage in human visceral adipose tissue from subjects with obesity and type 2 diabetes. Diabetes Research and Clinical Practice 106(3), 627-633.
  28. et. al. Research letter in relation to paper by Bongaerts et al., a clinical screening score for diabetic polyneuropathy: KORA F4 and AusDiab studies. Journal of Diabetes and its Complications
  29. & The causes of hypopituitarism in the absence of abnormal pituitary imaging. QJM 107(1), 21-24.
  30. & Does bariatric surgery adversely impact on diabetic retinopathy in persons with morbid obesity and type 2 diabetes? A pilot study. Journal of Diabetes and its Complications 28(2), 191-195.
  31. & Association of TERC and OBFC1 Haplotypes with Mean Leukocyte Telomere Length and Risk for Coronary Heart Disease. PLoS ONE 8(12), e83122
  32. & Cutaneous allergy to insulin: Could statins and ACE inhibitors play a role? A case report. Diabetes Research and Clinical Practice 104(1), e20-e22.
  33. & Simulated games activity vs continuous running exercise: A novel comparison of the glycemic and metabolic responses in T1DM patients. Scandinavian Journal of Medicine & Science in Sports, n/a-n/a.
  34. & Prevalence of Undiagnosed Cardiovascular Risk Factors and 10-Year CVD Risk in Male Steel Industry Workers. Journal of Occupational and Environmental Medicine 56(5), 535-539.
  35. & Temporal changes in glucose homeostasis and incretin hormone response at 1 and 6 months after laparoscopic sleeve gastrectomy. Surgery for Obesity and Related Diseases 10(5), 860-869.
  36. et. al. 'Prosiect Sir Gar': workplace-based cardiovascular disease and diabetes risk assessments. Occupational Medicine 64(7), 549-556.
  37. & Predicted 10-year risk of cardiovascular disease is influenced by the risk equation adopted: a cross-sectional analysis. British Journal of General Practice 64(627), e634-e640.
  38. Secretory Phospholipase A2-IIA and Cardiovascular Disease: a Mendelian randomization study. Journal of the American College of Cardiology 10.1016/j.jacc.2013.06.044, 10.1016/j.jacc.2013.06.044
  39. & Isolated B-cell non-Hodgkin's lymphoma of the parotid gland presenting as an ulcerating facial mass and sepsis during an acute medical take. Case Reports 2013(jan25 1), bcr2012008114-bcr2012008114.
  40. & Isomaltulose Improves Glycemia and Maintains Run Performance in Type 1 Diabetes. Medicine & Science in Sports & Exercise 44(5), 800-808.
  41. & The management of diabetes in terminal illness related to cancer. QJM 105(1), 3-9.
  42. & Association between the rs1050450 glutathione peroxidase-1 (C > T) gene variant and peripheral neuropathy in two independent samples of subjects with diabetes mellitus. Nutrition, Metabolism and Cardiovascular Diseases 22(5), 417-425.
  43. & The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. The Lancet 379(9822), 1214-1224.
  44. & Adrenal insufficiency following bariatric surgery. Obesity Reviews 13(6), 560-562.
  45. & Genetic Susceptibility for Coronary Heart Disease and Type 2 Diabetes Complications. Clinical Chemistry 58(5), 818-820.
  46. & Quality and Outcomes Framework screening questions for depression in patients with diabetes: effective but non-efficient. Diabetic Medicine 29(7), 957-958.
  47. & Association of a sequence variant in DAB2IP with coronary heart disease. European Heart Journal 33(7), 881-888.
  48. & Temporal changes in glucose and insulin homeostasis after biliopancreatic diversion and laparoscopic adjustable gastric banding.. Surg Obes Relat Dis.
  49. et. al. IRS1 gene variants, dysglycaemic metabolic changes and type-2 diabetes risk. Nutrition, Metabolism and Cardiovascular Diseases
  50. & Experience of the introduction of routine antibody testing in primary care and of running a trial for latent autoimmune diabetes in adults (LADA). Diabetes Research and Clinical Practice 93(1), e49-e52.
  51. & Persistent primary hypogonadism associated with anabolic steroid abuse. Fertility and Sterility 96(1), e7-e8.
  52. & Comment on: Polonsky et al. Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes: Results From the Structured Testing Program Study. Diabetes Care 2011;34:262-267. Diabetes Care 34(5), e57-e57.
  53. & Glycaemic control and other cardiovascular risk factors should be targeted independently in patients with type 2 diabetes mellitus. Atherosclerosis 217(1), 297-298.
  54. & Association of the adiponectin rs266729 C>G variant and coronary heart disease in the low risk ‘Golden Years’ type 1 diabetes cohort. Diabetes Research and Clinical Practice 91(3), e71-e74.
  55. & A combined insulin reduction and carbohydrate feeding strategy 30 min before running best preserves blood glucose concentration after exercise through improved fuel oxidation in type 1 diabetes mellitus. Journal of Sports Sciences 29(3), 279-289.
  56. & Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 94(2), 199-206.
  57. & Adiponectin, total antioxidant status, and urine albumin excretion in the low-risk "Golden Years" type 1 diabetes mellitus cohort. Metabolism-Clinical and Experimental, 173-179.
  58. & Isomaltulose Improves Postexercise Glycemia by Reducing CHO Oxidation in T1DM. Medicine & Science in Sports & Exercise 43(2), 204-210.
  59. & Genetic variants near IRS1 and their association with type 2 diabetes, Hyperinsulinemia and insulin resistance. Nutr Metab Cardiovasc Dis
  60. & Association of the adiponectin rs266729 C>G variant and coronary heart disease in the low risk ‘Golden Years’ type 1 diabetes cohort. Diabetes Research and Clinical Practice 91(3), e71-e74.
  61. & Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation. Atherosclerosis 209(1), 42-50.
  62. & Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation. Atherosclerosis 209(1), 42-50.
  63. & Apoplexy in a corticotrophin-secreting pituitary macroadenoma: a case report and review of the literature. QJM 103(8), 607-609.
  64. & Association between rs1050450 glutathione peroxidase-1 (C>T) gene variant and peripheral neuropathy in two independent samples of subjects with diabetes.. Nutrition, Metaoblism and Cardiovascular Disease
  65. & Adiponectin levels in people with Latent Autoimmune Diabetes-a case control study. BMC Research Notes 3(1), 317
  66. & Joint analysis of individual participants" data from 17 studies on the association of the IL6 variant-174GC with circulating glucose levels, interleukin-6 levels, and body mass index. Annals of Medicine, 128-38.
  67. & Association between the adiponectin promoter rs266729 gene variant and oxidative stress in patients with diabetes mellitus.. Eur Heart J, 1263-9.
  68. & The effect of WNT5B IVS3C > G on the susceptibility to type 2 diabetes in UK Caucasian subjects. Nutrition, Metabolism and Cardiovascular Disease, 140-145.
  69. Joint analysis of individual participants' data from 17 studies on the association of the IL6 variant-174GC with circulating glucose levels, interleukin-6 levels, and body mass index. , 128-38.
  70. & Interaction between the uncoupling protein 2 -866G > A gene variant and cigarette smoking to increase oxidative stress in subjects with diabetes. Nutrition, Metabolism and Cardiovascular Disease, 7-14.
  71. Variation in the UCP2-UCP3 Gene Cluster Predicts the Development of Type 2 Diabetes in Healthy Middle-Aged Men. Diabetes 55(5), 1504-1511.
  72. Increased Plasma Markers of Oxidative Stress Are Associated with Coronary Heart Disease in Males with Diabetes Mellitus and with 10-Year Risk in a Prospective Sample of Males. Clinical Chemistry 52(3), 446-452.
  73. Association between plasma levels of heat shock protein 60 and cardiovascular disease in patients with diabetes mellitus. European Heart Journal 27(13), 1565-1570.
  74. Tagging-SNP haplotype analysis of the secretory PLA2IIa gene PLA2G2A shows strong association with serum levels of sPLA2IIa: results from the UDACS study. Human Molecular Genetics 15(2), 355-361.